×
About 24,362 results

ALLMedicine™ Hypoglycemia Center

Research & Reviews  11,041 results

Towards enhanced understanding of idiopathic ketotic hypoglycemia: a literature review ...
https://doi.org/10.1186/s13023-021-01797-2 10.1007/978-1-4757-0734-2_8 10.1016/S0736-4679(03)00100-8 10.1097/00006565-199808000-00006 10.1093/nar/gky1105 10.1093/nar/gkz997 10.1016/S0022-3476(64)80611-9 10.1016/S0022-3476(73)80152-0 10.1136/adc.2005.089425 10.21037/tp.2017.10.05 10.1136/archdischild-2015-308337 10.1016/j.jpeds.2015.03.057 10.1016/B978-1-4557-4858-7.00030-5 10.1002/glia.20557 10.3389/fnins.2019.01176 10.1136/bmj.297.6659.1304 10.1542/peds.107.3.476 10.3389/fendo.2017.00156 10.1016/S0022-3476(81)80583-5 10.1542/peds.2010-1706 10.1007/BF02072043 10.1016/0009-8981(85)90015-4 10.1016/0009-8981(85)90186-X 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8 10.1111/1742-6723.13276 10.1016/j.pcl.2017.11.005 10.1007/s13149-010-0040-5 10.1016/S0140-6736(87)90354-0 10.1007/s10545-014-9744-1 10.1111/j.1651-2227.1979.tb18433.x 10.1038/nrendo.2016.138 10.1515/JPEM.2005.18.7.663 10.1007/s00431-007-0598-5 10.1172/JCI106940 10.1210/jc.2008-1410 10.1016/S0889-8529(05)70084-0 10.2337/diabetes.54.10.2946 10.1016/S0300-595X(83)80051-6 10.1186/s13633-019-0066-9 10.3329/bjch.v43i2.42567 10.1038/s41598-020-58845-3 10.1016/B978-0-444-53491-0.00023-7 10.1111/j.1365-2265.2008.03184.x 10.1111/j.1365-2265.2011.04250.x 10.1002/jmd2.12041 10.1056/NEJMoa1407778 10.3389/fped.2019.00299 10.1038/gim.2014.128 10.1172/JCI115803 10.1172/JCI114619 10.1097/01.ASN.0000092790.89332.D2 10.1093/nar/gkt977 10.1210/jc.2007-0661 10.1016/j.earlhumdev.2010.05.005 10.1136/archdischild-2013-304682 10.1542/peds.2010-3851 10.1007/8904_2015_488 10.1111/cch.12628
Orphanet Journal of Rare Diseases; Drachmann D, Hoffmann E et. al.

Apr 14th, 2021 - Idiopathic Ketotic hypoglycemia (IKH) is a diagnosis of exclusion. Although considered as the most frequent cause of hypoglycemia in childhood, little progress has been made to advance the understanding of IKH since the medical term was coined in ...

Association Between the CYP2C9 Genotype and Hypoglycemia Among Patients With Type 2 Dia...
https://doi.org/10.1016/j.clinthera.2021.03.008
Clinical Therapeutics; Yee J, Heo Y et. al.

Apr 12th, 2021 - Two common variants, CYP2C9*2 (Arg144Cys, rs1799853) and CYP2C9*3 (Ile359Leu, rs1057910), are known to reduce the catalytic function of the CYP2C9 enzyme. Because impaired catalytic function is likely to affect sulfonylurea metabolism, it is predi...

Economic burden of diabetes-related hypoglycemia on patients, payors, and employers.
https://doi.org/10.1016/j.jdiacomp.2021.107916
Journal of Diabetes and Its Complications; Shi L, Fonseca V et. al.

Apr 10th, 2021 - The economic and psychological consequences of diabetes-related hypoglycemic events are multifold and shared across various parties, including patients and their family or caregivers, payors, and employers. Hypoglycemic events contribute to increa...

"Hyperglycemia aversiveness": Investigating an overlooked problem among adults with typ...
https://doi.org/10.1016/j.jdiacomp.2021.107925
Journal of Diabetes and Its Complications; Polonsky WH, Fortmann AL et. al.

Apr 10th, 2021 - To investigate the problem of adults with type 1 diabetes (T1D) who purposefully keep their glucose levels low, and to explore contributors to, and possible impact of, this potentially dangerous phenomenon. We developed three self-report items as ...

ABM Clinical Protocol #1: Guidelines for Glucose Monitoring and Treatment of Hypoglycem...
https://doi.org/10.1089/bfm.2021.29178.new
Breastfeeding Medicine : the Official Journal of the Acad... Wight NE,

Apr 9th, 2021 - A central goal of The Academy of Breastfeeding Medicine is the development of clinical protocols for managing common medical conditions that may impact breastfeeding success. These protocols serve only as guidelines for the care of breastfeeding m...

see more →

Guidelines  49 results

Management and Appropriate Use of Diazoxide in Infants and Children with Hyperinsulinism.
https://doi.org/10.1210/clinem/dgaa543
The Journal of Clinical Endocrinology and Metabolism; Brar PC, Heksch R et. al.

Aug 18th, 2020 - The diagnosis of hypoglycemia and the use of diazoxide have risen in the last decade. Diazoxide is the only Food and Drug Agency-approved pharmacologic treatment for neonatal hypoglycemia caused by hyperinsulinism (HI). Recent publications have hi...

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
https://www.nejm.org/doi/full/10.1056/NEJMoa1911303
The New England Journal of Medicine; McMurray,J.,et al

Sep 18th, 2019 - BACKGROUND In patients with type 2 diabetes, inhibitors of sodium–glucose cotransporter 2 (SGLT2) reduce the risk of a first hospitalization for heart failure, possibly through glucose-independent mechanisms. More data are needed regarding the eff...

Xeris Pharmaceuticals Receives U.S. Fda Approval For Gvoke™ (Glucagon), The First Ready-to-use Stable Liquid Glucagon For Severe Hypoglycemia
https://xerispharma.gcs-web.com/news-releases/news-release-details/xeris-pharmaceuticals-receives-us-fda-approval-gvoketm-glucagon

Sep 9th, 2019 - Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced today that it has received reg...

BAQSIMI™ (glucagon) Nasal Powder 3 mg, the First and Only Nasally Administered Glucagon to Treat Severe Hypoglycemia in Adults and Children with Diabetes Ages Four Years and Older, Approved by FDA
https://investor.lilly.com/news-releases/news-release-details/baqsimitm-glucagon-nasal-powder-3-mg-first-and-only-nasally

Jul 23rd, 2019 - The U.S. Food and Drug Administration (FDA) has approved BAQSIMI™ (glucagon) nasal powder 3 mg for the treatment of severe hypoglycemia in people with diabetes ages four years and above, Eli Lilly and Company (NYSE: LLY) announced today. BAQSIMI i...

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors
http://care.diabetesjournals.org/content/42/6/1147
Diabetes Care; Danne,T.,et al

May 31st, 2019 - Sodium–glucose cotransporter (SGLT) inhibitors are new oral antidiabetes medications shown to effectively reduce glycated hemoglobin (A1C) and glycemic variability, blood pressure, and body weight without intrinsic properties to cause hypoglycemia...

see more →

Drugs  93 results see all →

Clinicaltrials.gov  11,921 results

Towards enhanced understanding of idiopathic ketotic hypoglycemia: a literature review ...
https://doi.org/10.1186/s13023-021-01797-2 10.1007/978-1-4757-0734-2_8 10.1016/S0736-4679(03)00100-8 10.1097/00006565-199808000-00006 10.1093/nar/gky1105 10.1093/nar/gkz997 10.1016/S0022-3476(64)80611-9 10.1016/S0022-3476(73)80152-0 10.1136/adc.2005.089425 10.21037/tp.2017.10.05 10.1136/archdischild-2015-308337 10.1016/j.jpeds.2015.03.057 10.1016/B978-1-4557-4858-7.00030-5 10.1002/glia.20557 10.3389/fnins.2019.01176 10.1136/bmj.297.6659.1304 10.1542/peds.107.3.476 10.3389/fendo.2017.00156 10.1016/S0022-3476(81)80583-5 10.1542/peds.2010-1706 10.1007/BF02072043 10.1016/0009-8981(85)90015-4 10.1016/0009-8981(85)90186-X 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8 10.1111/1742-6723.13276 10.1016/j.pcl.2017.11.005 10.1007/s13149-010-0040-5 10.1016/S0140-6736(87)90354-0 10.1007/s10545-014-9744-1 10.1111/j.1651-2227.1979.tb18433.x 10.1038/nrendo.2016.138 10.1515/JPEM.2005.18.7.663 10.1007/s00431-007-0598-5 10.1172/JCI106940 10.1210/jc.2008-1410 10.1016/S0889-8529(05)70084-0 10.2337/diabetes.54.10.2946 10.1016/S0300-595X(83)80051-6 10.1186/s13633-019-0066-9 10.3329/bjch.v43i2.42567 10.1038/s41598-020-58845-3 10.1016/B978-0-444-53491-0.00023-7 10.1111/j.1365-2265.2008.03184.x 10.1111/j.1365-2265.2011.04250.x 10.1002/jmd2.12041 10.1056/NEJMoa1407778 10.3389/fped.2019.00299 10.1038/gim.2014.128 10.1172/JCI115803 10.1172/JCI114619 10.1097/01.ASN.0000092790.89332.D2 10.1093/nar/gkt977 10.1210/jc.2007-0661 10.1016/j.earlhumdev.2010.05.005 10.1136/archdischild-2013-304682 10.1542/peds.2010-3851 10.1007/8904_2015_488 10.1111/cch.12628
Orphanet Journal of Rare Diseases; Drachmann D, Hoffmann E et. al.

Apr 14th, 2021 - Idiopathic Ketotic hypoglycemia (IKH) is a diagnosis of exclusion. Although considered as the most frequent cause of hypoglycemia in childhood, little progress has been made to advance the understanding of IKH since the medical term was coined in ...

Association Between the CYP2C9 Genotype and Hypoglycemia Among Patients With Type 2 Dia...
https://doi.org/10.1016/j.clinthera.2021.03.008
Clinical Therapeutics; Yee J, Heo Y et. al.

Apr 12th, 2021 - Two common variants, CYP2C9*2 (Arg144Cys, rs1799853) and CYP2C9*3 (Ile359Leu, rs1057910), are known to reduce the catalytic function of the CYP2C9 enzyme. Because impaired catalytic function is likely to affect sulfonylurea metabolism, it is predi...

Economic burden of diabetes-related hypoglycemia on patients, payors, and employers.
https://doi.org/10.1016/j.jdiacomp.2021.107916
Journal of Diabetes and Its Complications; Shi L, Fonseca V et. al.

Apr 10th, 2021 - The economic and psychological consequences of diabetes-related hypoglycemic events are multifold and shared across various parties, including patients and their family or caregivers, payors, and employers. Hypoglycemic events contribute to increa...

"Hyperglycemia aversiveness": Investigating an overlooked problem among adults with typ...
https://doi.org/10.1016/j.jdiacomp.2021.107925
Journal of Diabetes and Its Complications; Polonsky WH, Fortmann AL et. al.

Apr 10th, 2021 - To investigate the problem of adults with type 1 diabetes (T1D) who purposefully keep their glucose levels low, and to explore contributors to, and possible impact of, this potentially dangerous phenomenon. We developed three self-report items as ...

ABM Clinical Protocol #1: Guidelines for Glucose Monitoring and Treatment of Hypoglycem...
https://doi.org/10.1089/bfm.2021.29178.new
Breastfeeding Medicine : the Official Journal of the Acad... Wight NE,

Apr 9th, 2021 - A central goal of The Academy of Breastfeeding Medicine is the development of clinical protocols for managing common medical conditions that may impact breastfeeding success. These protocols serve only as guidelines for the care of breastfeeding m...

see more →

News  1,211 results

FDA Approves New Ready-to-Inject Glucagon Product
https://www.medscape.com/viewarticle/947962

Mar 22nd, 2021 - The US Food and Drug Administration (FDA) has approved dasiglucagon (Zegalogue 0.6 mg/0.6 mL, Zealand Pharma) autoinjector and prefilled syringe for the treatment of severe hypoglycemia in people with diabetes aged 6 and older. The product has a s...

Pumps and Patches: Technology Benefits Youth With Type 1 Diabetes
https://www.medscape.com/viewarticle/947742

Mar 18th, 2021 - An increase in the use of insulin pumps and continuous glucose monitoring (CGM) around the world is benefiting children with type 1 diabetes, new research finds. An analysis of data for more than 25,000 participants aged 18 years or younger with t...

Less Risk of Severe Hypoglycemia With Long-Acting Insulin Analogs in Elderly
https://www.medscape.com/viewarticle/946662

Mar 1st, 2021 - NEW YORK (Reuters Health) - Long-acting insulin analogs may be a safer option than neutral protamine Hagedorn (NPH, also known as isophane insulin) in elderly patients with type 2 diabetes initiating insulin therapy, according to a large observati...

Continuous Glucose Monitoring Curbs Hyperglycemia, Hypoglycemia in Preemies
https://www.medscape.com/viewarticle/946348

Feb 24th, 2021 - NEW YORK (Reuters Health) - In preterm infants, continuous glucose monitoring (CGM) reduced prolonged or severe hyperglycemia and hypoglycemia in an international randomized controlled trial. Both conditions "are associated with long-term harm," D...

High Glucose in Kids With Type 1 Diabetes 'Noxious to the Brain'
https://www.medscape.com/viewarticle/946379

Feb 23rd, 2021 - Type 1 diabetes appears to affect cognitive development in young children, with adverse effects persisting over time, and with strong associations with long- and short-term hyperglycemia, a new longitudinal study shows. "[The results show] the bra...

see more →

Patient Education  47 results see all →